‘Unhappy’ pupils more likely to be smokers and drinkers
The report also revealed that 2% of pupils had recently smoked, drunk alcohol and taken drugs and 11% had done only one of these recent behaviours.
Read More
Author: Anna Smith
Sarepta’s DMD drug hit with FDA Complete Response Letter
The company say they are “surprised” to have received the letter.
Read More
£3.3m boost for mental illness in children
The funding comes as part of the government’s commitment to transforming mental health care.
Read More
Positive results continue success for Forxiga
Forxiga has had a string of successes recently, as it was recommended by NICE and had its EU marketing authorisation updated earlier this month.
Read More
Nationwide sepsis push saves ‘hundreds of lives’
The drive includes a one-hour identification and treatment ambition, as well as a new ‘alert and action’ technology.
Read More- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
